Response to Neoadjuvant Therapy and Prognosis in Patients with Resectable Pancreatic Cancer: A Propensity Score Matching Analysis

BACKGROUND/AIMS: Controversy regarding the effectiveness of neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma (PDAC) still exists. Here, we aimed to identify the potential benefits of neoadjuvant therapy followed by surgery for resectable PDAC. METHODS: We reviewed radiologically r...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Min Sung, Lee, Hee Seung, Kang, Chang Moo, Lee, Woo Jung, Keum, Jiyoung, Sung, Min Je, Kim, Seung-seob, Park, Mi-Suk, Jo, Jung Hyun, Chung, Moon Jae, Park, Jeong Youp, Park, Seung Woo, Song, Si Young, Hwang, Ho Kyoung, Bang, Seungmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761915/
https://www.ncbi.nlm.nih.gov/pubmed/34140428
http://dx.doi.org/10.5009/gnl20301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761915/
https://www.ncbi.nlm.nih.gov/pubmed/34140428
http://dx.doi.org/10.5009/gnl20301

Ejemplares similares